Entity
Description
  • Value proposition

    We use AI to find the right treatment for every patient.

    Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner.

    We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from siloed datasets while protecting patient privacy and securing proprietary data.

    Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).

    artificial intelligence, omics technology, oncology, drug discovery, medical research, biomedical images, real-world data, real world evidence, radiology, clinical data, federated learning, covariate adjustment, clinical tools, digital pathology, healthcare, diagnostic solutions, biomarkers, precision medicine, and data science

  • Understanding complex biology through AI | Owkin

    We integrate the best of human and artificial intelligence to deliver better drugs and diagnostics at scale.

  • https://www.owkin.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Ministère de l'Enseignement supérieur et de la Recherche Ministère de l'Enseignement supérieur et de la Recherche
Government Administration
Other

18 Mar 2021


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

8 Nov 2024


United Nations Office for Disarmament Affairs
United Nations Office for Disarmament Affairs
International development, International Affairs
United Nations Office for Disarmament Affairs
International development, International Affairs
Other

11 Feb 2023


Hexa
Hexa
Software Development
Hexa
Software Development
Other

6 Jul 2022


Sifted
Sifted
Newspaper Publishing
Sifted
Newspaper Publishing
Capitalistic
Not partnership
Not event

18 Nov 2021


Google
Google
IT services, Software Development
Google
IT services, Software Development
Other

1 Mar 2023

30 Oct 2024



Financial Times
Financial Times
Media, Newspaper Publishing
Financial Times
Media, Newspaper Publishing
Other

2 Jun 2023

31 May 2023



Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Not capitalistic
Partnership
Event

16 Jun 2023

30 Sep 2024



Techstars
Techstars
Startup accelerator & VC, Venture Capital & Private Equity
Techstars
Startup accelerator & VC, Venture Capital & Private Equity
Other

27 Mar 2019


Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care
Not capitalistic
Partnership
Event

19 Jan 2023

23 Jan 2023



Similar entities
Loading...
Loading...
Social network dynamics